Medipharm Labs Corp T.LABS

Trump Supports Rescheduling and Banking !!!! $$$$

[1hot-techwoman]

https://www.youtube.com/watch?v=znwkPMqKSxA

[Hunter34]

This post has been removed in accordance with Community Policy

[1hot-techwoman]

DJ Marijuana Stocks Climb After Trump Claims Support for Cannabis Reform Monday, September 9, 2024, 1:10 PM ET   By Dean Seal Shares of cannabis stocks have a strong start to the week after former President Donald Trump said he would support marijuana overhaul, easing concerns that he might undo the Biden administration's efforts to loosen regulations if he wins the

[moose73]

Shares of cannabis stock all going up except for this junk but it for sure goes down on bad market days. 

[QContinuum1]

Exactly this.  Even though LABS generally won't benefit (at least not quickly) anything to do with rescheduling, LABS does not move up with updrafts but certainly moves lower on downdrafts.  Not sure why that is.  Leadership needs to step up here and get something positive moving.

[Starkicker]

Without some kind of positive news, the looming general market correction will take this POS to new, possibly dangerous, lows. I mean, two months ago I bought shares at 7 cents with a sell order for 8 cents and it never got there. You won't find a horse more dead than this. Life in the microcap world...lol.

[QContinuum1]

I've averaged down and have bought plenty more than I should have applying your exact thinking.  And it's only gotten me a very uncomfortable gnawing pain in the groin area. I'm hopeful that the leadership team are on top of what is needed to get top line up.  I have faith in Pidduck but I have to admit that faith is waning a bit.  So much silence and so little positive

[subaru1]

That will not change much for Labs, there is already 36 state in which the medical marijuana is legal, the real problem is the LEADERSHIP and the RELATION with the investors. They also have around $16 millions in the bank since almost a year and nothing is being done with it, also look at at their investment in R&D almost 0.

[CADInvestor12]

IR problem, yes - Leadership problem, no. Pidduck is one of, if not the top CEO in the cannabis space. Now that they are approaching positive adj EBITDA, fingers crossed that they will deploy resources aggressively. While frustrating, it is refreshing to see a disciplined approach from management vs the rest of the industry. Once (if) rescheduling happens, hopefully they can capitalize on the

[Starkicker]

Pidduck did make a mistake by projecting positive EBITDA too early, which is a rookie error. Suggests that whatever they were expecting to generate some top line growth misfired, replaced by cost cutting. Hopefully just a temporary setback but it will be a year come November earnings since he said that. I'm holding on to the nice share issuances directors received last Q4. Makes me think the

[subaru1]

Top line growth is number one and cost saving is number two eps is number tree, he missed number one drastically, cost saving ok and eps should be in the 4 qrt, Top line has to grow at least 20% by qrt for the next 2 years to move the stock price in a decent price.

[subaru1]

By the way i am all in anyway to late to give up, sitting here and still waiting like many of us, we are certainly at the bottom at $0,06